Akbar et al. reported that exoPD-L1 from non-small cell lung cancer (NSCLC) patients and healthy controls showed a significantly higher difference than corresponding serum and tissue PD-L1 (97). This evidence concerns the gene CD274 and non-small cell lung carcinoma.